Symrise AG
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Symrise AG (SYIEF) develops, manufactures and markets fragrances, flavors, cosmetic active ingredients, functional ingredients and nutrition solutions worldwide. The company operates through two primary segments: Taste, Nutrition & Health, which offers savory and sweet flavors, natural and sustainable ingredients for food and beverages, pet food solutions, probiotics for supplements and functional foods, and sustainable ingredients for aquaculture; and Scent & Care, which provides fragrance compositions and aroma molecules for perfumes, personal care and oral care products, as well as cosmetic base materials, active ingredients and mint flavors for cleaning products, detergents and air fresheners. Its approximately 35,000 products, largely derived from natural raw materials such as vanilla, citrus, blossoms and plant extracts, serve manufacturers in the perfume, cosmetics, food and beverage, pharmaceutical, pet food, baby food and supplement industries. Founded in 2003 through the merger of Haarmann & Reimer and Dragoco—whose roots trace back to 1874—Symrise AG maintains its corporate headquarters in Holzminden, Germany, with regional headquarters in Rennes (France), Teterboro (New Jersey, USA), São Paulo (Brazil) and Singapore. The company conducts operations across more than 100 sites in roughly 150 countries, including Europe, Africa, the Middle East, North America, Asia Pacific and Latin America, employing over 12,000 people and generating 2024 sales of €4,999 million. Among recent developments, Symrise established a strategic partnership with Aplantex Bio in October 2025 to access innovative green biotechnology for producing hard-to-source plant-based molecules like apigenin, orientin, vitexin and luteolin, addressing climate-related supply challenges in cosmetics, nutrition and health applications. The company also invested in biotech firm Cellibre in 2025 to advance precision fermentation technologies for natural, high-value flavor and cosmetic actives. In October 2025, Symrise issued an €800 million seven-year bond to support ongoing investments, while launching the Symvision AI platform for proprietary taste development and the 'Houston' digital tool for CO2 emissions tracking ahead of COP30, alongside partnerships for rainforest protection in Honduras and Suriname.
Symrise AG (SYIEY) Q2 2026 Earnings Call Transcript
Symrise Q2 Earnings Call Highlights
Symrise AG (SYIEY) Q1 2026 Earnings Call Transcript
Symrise: Good Improvements, But Growth Outlook, It Is Not Entirely Clear
Symrise (SYIEY) Upgraded to Buy: What Does It Mean for the Stock?
Symrise AG (SYIEY) Q4 2025 Earnings Call Transcript
Oakmark International Strategy Q4 2025 New Investments And Divestments
What Makes Symrise (SYIEY) a New Buy Stock
Axalta Coating Systems (NYSE:AXTA) vs. Symrise (OTCMKTS:SYIEY) Head to Head Analysis
Harding Loevner International Equity ADR Q3 2025 Portfolio Update
The Moat Might Be Narrow, But Symrise Looks Undervalued (Rating Upgrade)
Symrise AG (SYIEF) H1 2025 Earnings Call Transcript
Hofseth Biocare ASA: HBC ACCELERATES IN HUMAN HEALTH AND PET NUTRITION THROUGH A STRATEGIC PARTNERSHIP WITH SYMRISE TO BUILD OUT BERKÅK, TRIPLING THE MANUFACTURING CAPACITY OF THE GROUP
Symrise AG (SYIEF) Q3 2024 Earnings Call Transcript
Symrise AG (SYIEF) Q2 2024 Earnings Call Transcript
European Dividend Gems: Symrise AG